Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

899 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas.
Diehl AC, Hannan LM, Zhen DB, Coveler AL, King G, Cohen SA, Harris WP, Shankaran V, Wong KM, Green S, Ng N, Pillarisetty VG, Sham JG, Park JO, Reddi D, Konnick EQ, Pritchard CC, Baker K, Redman M, Chiorean EG. Diehl AC, et al. Among authors: park jo. Oncologist. 2022 Dec 9;27(12):1025-1033. doi: 10.1093/oncolo/oyac179. Oncologist. 2022. PMID: 36124727 Free PMC article.
Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.
Sham JG, Kievit FM, Grierson JR, Miyaoka RS, Yeh MM, Zhang M, Yeung RS, Minoshima S, Park JO. Sham JG, et al. Among authors: park jo. J Nucl Med. 2014 May;55(5):799-804. doi: 10.2967/jnumed.113.132118. Epub 2014 Mar 13. J Nucl Med. 2014. PMID: 24627434 Free PMC article.
mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.
Riehle KJ, Yeh MM, Yu JJ, Kenerson HL, Harris WP, Park JO, Yeung RS. Riehle KJ, et al. Among authors: park jo. Mod Pathol. 2015 Jan;28(1):103-10. doi: 10.1038/modpathol.2014.78. Epub 2014 Jun 13. Mod Pathol. 2015. PMID: 24925055 Free article.
Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma.
Sham JG, Kievit FM, Grierson JR, Chiarelli PA, Miyaoka RS, Zhang M, Yeung RS, Minoshima S, Park JO. Sham JG, et al. Among authors: park jo. J Nucl Med. 2014 Dec;55(12):2032-7. doi: 10.2967/jnumed.114.145102. Epub 2014 Oct 30. J Nucl Med. 2014. PMID: 25359880 Free PMC article.
Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched Study.
Padia SA, Johnson GE, Horton KJ, Ingraham CR, Kogut MJ, Kwan S, Vaidya S, Monsky WL, Park JO, Bhattacharya R, Hippe DS, Harris WP. Padia SA, et al. Among authors: park jo. J Vasc Interv Radiol. 2017 Jun;28(6):777-785.e1. doi: 10.1016/j.jvir.2017.02.018. Epub 2017 Mar 30. J Vasc Interv Radiol. 2017. PMID: 28365172
Toward consensus reporting of radiation-induced liver toxicity in the treatment of primary liver malignancies: Defining clinically relevant endpoints.
Chapman TR, Bowen SR, Schaub SK, Yeung RH, Kwan SW, Park JO, Yu L, Harris WP, Johnson GE, Liou IW, Nyflot MJ, Apisarnthanarax S. Chapman TR, et al. Among authors: park jo. Pract Radiat Oncol. 2018 May-Jun;8(3):157-166. doi: 10.1016/j.prro.2017.10.013. Epub 2017 Nov 4. Pract Radiat Oncol. 2018. PMID: 29426691
899 results